Abbott Laboratories on track for new highs in 2024

Key PointsAbbott Laboratories' share price fell sharply following solid results, setting up a buying opportunity. The company is transitioning back to core organic growth after years of COVID-19 impacts.Analysts are raising their price targets and may drive the stock to break out of its trading range. 5 stocks we like better than Abbott LaboratoriesAbbott Laboratories NYSE: ABT share price fell following its Q4 2023 results, but investors should be cheering the news. The decline is a response to a report th ...